Manipal Hospitals launches Radixact System with Synchrony technology in India

Synchrony, revolutionises cancer treatment by its precision and flexibility

Manipal Hospitals has launched the first-of-its-kind advanced Radixact System with Synchrony Automatic, a real-time motion synchronisation technology, for the precise treatment of cancer patients. Manipal Hospitals has obtained the requisite license from AERB for Radixact X9 Tomotherapy with Synchrony tumour tracking technology. 


The Radixact system, with its new generation of Tomotherapy with Synchrony technology, serves cancer patient needs, by far superior clinical results in head and neck, breast, GI and prostate cancers, which consolidate for more than 85 per cent of occurrence. The system delivers 360 degree rotational delivery for the whole body and CT based daily IGRT treatment with Iterative reconstruction. The combined technologies enable the delivery of radiation using a variety of methods — from image-guided intensity-modulated radiation therapy (IG-IMRT) to stereotactic body radiation therapy (SBRT) — to treat almost any tumour, even those that move with breathing, precision, accuracy and unprecedented flexibility.

Dr Vadhiraja BM, HOD & Consultant – Radiotherapy, Manipal Hospitals, Old Airport Road stated, “ The synchrony technology is expected to revolutionise cancer treatment by significantly lowering the discomfort undergone by cancer patients. Synchrony for the Radixact System will provide clinicians with the technology they need to effectively and efficiently treat cancer patients requiring radiation therapy, in whom the tumour moves while breathing.”

Dr Vadhiraja B M added, “The technology helps in minimising the extra margin given around the tumour, thereby minimising the radiation dose to the surrounding normal lung and finally delivering the highest tolerated dose required to destroy the cancer cells.”

Support us in our endeavor to bring you Advertisement free content.
Choose your options to donate or subscribe.


Related Articles

Leave a Reply

Back to top button